Ryan Specialty’s compensation costs grew nearly twice as fast as its revenue in the third quarter of 2026, a detail buried beneath the headline numbers.
Total revenue reached US$790 million (around £589.7 million) in the three months to September 30, up 4.7% year-over-year. Compensation and benefits expenses rose 9.9% to US$484.2 million (around £361.4 million) over the same period. That gap pushed the GAAP compensation and benefits ratio to 61.3%, against 58.4% a year earlier, and to 60.4% over nine months. For a business whose model depends on talent to win and retain specialty placements, paying more per dollar of revenue earned is manageable in the short term, but it is a pressure the company is now actively working to reduce.
That pressure is what prompted the Empower Program, a three-year restructuring initiative approved by Ryan Specialty’s board in early 2026. It has already cost $63.1 million (around £47.1 million) in restructuring charges through the nine months to September 30, including $23.9 million (around £17.8 million) in the third quarter across compensation and general and administrative costs combined. The program is targeting US$80 million (around £59.7 million) in annual savings by 2029, primarily through platform optimization and back-office streamlining, against total projected charges of US$160 million (around £119.4 million) through 2028. The savings are still years away.
Ryan Specialty reported growth across the majority of its casualty lines and a decline in its property book. That split reflects market conditions running across the wider specialty market: excess and surplus (E&S) property rates are down sharply as capacity has returned, while casualty lines remain firmer on the back of social inflation, litigation cost pressure, and tightening limits.
Ryan Specialty’s London operations sit inside that softening cycle. The company holds a significant presence in the London wholesale market through RT Specialty London and its Ryan Specialty Underwriting Managers International unit, which completed a series of Lloyd’s consortium stamps backed by six leading syndicates in 2026.
Across the Lloyd’s market as a whole, risk-adjusted rates fell 6.7% in the first half of 2026, nearly double the pace of the same period a year earlier. That rate environment puts pressure on any wholesale intermediary earning commission on placements where pricing has moved against the market.
The specialty market as a whole has given back 65% of the rate gains it achieved during the hard market, according to a WTW’s Global Insurance Market Index survey covering the first half of 2026. The data identified casualty as the line most at risk on pricing adequacy, not because rates are falling fastest there, but because loss costs continue to rise against premiums that are no longer keeping pace.
Organic revenue growth in Ryan Specialty’s third quarter was 4.0%, against a 15.0% comparison from the same period a year earlier, when hard-market conditions were at or near their peak. The nine-month organic growth rate is 7.3%.
The segment mix inside the results points to where Ryan Specialty has found cover from the rate headwinds. Underwriting management, the segment where Ryan Specialty’s managing general underwriters hold binding authority from carriers, grew 17.3% over nine months and expanded its share of net commissions and fees from 33.5% to 36.0%. Wholesale brokerage, the larger segment at around half of revenues, grew 4.6% in the same period.
The structural reason delegated authority holds up better in a softening market is that revenue there is tied to premiums underwritten rather than commissions on placements where the rate has moved against the broker. It is a partial buffer, not a hedge, but over nine months it has made a measurable difference to Ryan Specialty’s revenue mix.
Net income rose 40.6% to US$88 million (around £65.7 million) in the quarter, aided by a sharp reversal in contingent consideration, from an US$11.9 million (around £8.9 million) expense in the same period a year earlier to a US$10.7 million (around £8 million) credit in Q3 2026, alongside lower acquisition-related costs.
Ryan Specialty maintained its full-year guidance for organic revenue growth in the mid-single digits and guided its adjusted EBITDAC margin to a modest decline versus the prior year. Chief executive Timothy W. Turner called the environment “one of the most challenging markets we have ever seen,” while Patrick G. Ryan, founder and executive chairman, said the company’s results reflected the strength of its platform heading into what he described as an increasingly difficult comparison period.
